Table 2 CSF cell distribution of PML subgroups
From: Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy
MS/NTZ group (n = 48) | HIV group (n = 15) | Lymphoma group (n = 10) | Transplant group (n = 7) | NPH + IIH group (n = 21) | HIV control group (n = 37) | Ms control group (n = 54) |
|---|---|---|---|---|---|---|
Lymphocytic predominance in 84% Granulocytic predominance in 4% Monocytic predominance in 4% Mixed cell distribution in 8% | Lymphocytic predominance in 87% Monocytic predominance in 6.5% Mixed cell distribution in 6.5% | Lymphocytic predominance in 65% Monocytic predominance in 29% Mixed cell distribution in 6% | Lymphocytic predominance in 86% Monocytic predominance in 14% | Lymphocytic predominance in 95% Monocytic predominance in 5% | Lymphocytic predominance in 85% Monocytic predominance in 3% Mixed cell distribution in 12% | Lymphocytic predominance in 98% Monocytic predominance in 2% |